title: Myeloid growth factors.
authors: Duke Cancer Institute, USA.
authors: Jeffrey
authors: J
authors: Crawford
authors: Jeffrey
authors: J
authors: Allen
authors: James
authors: J
authors: Armitage
authors: Douglas W
authors: DW
authors: Blayney
authors: Spero R
authors: SR
authors: Cataland
authors: Mark L
authors: ML
authors: Heaney
authors: Sally
authors: S
authors: Htoy
authors: Susan
authors: S
authors: Hudock
authors: Dwight D
authors: DD
authors: Kloth
authors: David J
authors: DJ
authors: Kuter
authors: Gary H
authors: GH
authors: Lyman
authors: Brandon
authors: B
authors: McMahon
authors: David P
authors: DP
authors: Steensma
authors: Saroj
authors: S
authors: Vadhan-Raj
authors: Peter
authors: P
authors: Westervelt
authors: Michael
authors: M
authors: Westmoreland
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects*; D017024:Chemotherapy, Adjuvant; D002986:Clinical Trials as Topic; D003115:Colony-Stimulating Factors / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D004359:Drug Therapy, Combination; D005334:Fever / Q000139:chemically induced / Q000188:drug therapy / Q000517:prevention & control*; D006801:Humans; D009190:Myelodysplastic Syndromes / Q000139:chemically induced / Q000188:drug therapy / Q000517:prevention & control*; D009369:Neoplasms / Q000188:drug therapy*; D009503:Neutropenia / Q000139:chemically induced / Q000517:prevention & control*; D018570:Risk Assessment; D012307:Risk Factors
chemical_list: D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D003115:Colony-Stimulating Factors